Shin Poong Pharm is engaged in the development and production of innovative pharmaceutical products, with a particular focus on addressing tropical diseases. One of their flagship products is Pyramax, which is designed to treat malaria and is recognized for its efficacy and safety. The company emphasizes its commitment to research and development (R&D), showcasing a robust pipeline of active pharmaceutical ingredients (APIs) and products aimed at improving health outcomes. Their R&D efforts are supported by a dedicated Tropical Diseases Drug Center, which aims to foster advancements in treatments for neglected diseases.

In addition to their product offerings, Shin Poong Pharm places a strong emphasis on collaboration and partnerships within the pharmaceutical industry. This approach not only enhances their R&D capabilities but also facilitates the development of new therapies. The company’s corporate philosophy and vision reflect a commitment to innovation and global health, positioning Shin Poong Pharm as a key player in the pharmaceutical landscape, particularly in the realm of tropical disease treatment.

South Korea

SHINPOONG PHARMACEUTICAL CO.,LTD. is a pharmaceuticals company based out of 733-23 Yoksam-Dong,Kangnam-Gu,Seoul, Seoul, South Korea.

Shin Poong Pharm

Company Details